# US 12,594,118 B2 · Systems, devices, and associated methods for neuromodulation with enhanced nerve targeting

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 12,594,118 B2
- Document ID: US12594118B2
- Status: Granted
- Kind: B2
- Application number: 18/501,507
- Filed: 2023-11-03
- Published: 2024-02-29
- Granted: 2026-04-07
- Earliest claimed: 2017-11-17
- Assignees: Medtronic Ireland Manufacturing Unlimited Company
- Applicants: Medtronic Ireland Manufacturing Unlimited Company
- Inventors: Douglas A. Hettrick; Julie Trudel; Paul Coates; Robert J. Melder; Stefan S. Tunev; Martin Rothman; Sean Salmon
- Web page: https://patentgrep.com/patent/US12594118B2

## CPC

- A61B 18/1492: {having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence)}
- A61B 5/0538: invasively, e.g. using a catheter
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 5/0035: {adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography}
- A61B 5/0036: {including treatment, e.g., using an implantable medical device, ablating, ventilating}
- A61B 5/0531: Measuring skin impedance
- A61B 2018/00404: {Blood vessels other than those in or around the heart}
- A61B 2018/00434: {Neural system}
- A61B 2018/00577: {Ablation}
- A61B 2018/00636: {Sensing and controlling the application of energy}
- A61B 2018/00642: {with feedback, i.e. closed loop control}
- A61B 2018/00648: {using more than one sensed parameter}
- A61B 2018/00654: {with individual control of each of a plurality of energy emitting elements}
- A61B 2018/00666: {using a threshold value}
- A61B 2018/00702: {Power or energy}
- A61B 2018/00755: {Resistance or impedance}
- A61B 2018/00875: {Resistance or impedance}
- A61B 2018/124: {switching the output to different electrodes, e.g. sequentially}
- A61B 2018/1467: {using more than two electrodes on a single probe}
- A61B 2018/165: {Multiple indifferent electrodes}
- A61B 2018/167: {Passive electrodes capacitively coupled to the skin}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Systems and methods for neuromodulation therapy are disclosed herein. A method in accordance with embodiments of the present technology can include, for example, positioning a plurality of reference electrodes at the skin of a human patient and intravascularly positioning a plurality of ablation electrodes within a blood vessel lumen at a treatment site. The method can include obtaining impedance measurements between different combinations of the reference electrodes and the ablation electrodes and, based on the impedance measurements, identifying two or more electrode groups for treatment, where at least two of the electrode groups include a different one of the reference electrodes and a different one of the ablation electrodes.

## Claims

### Claim 1

A system comprising:
a controller configured to:
obtain impedance measurements for a plurality of electrode groups, wherein each electrode group of the plurality of electrode groups includes a neuromodulation electrode of a plurality of neuromodulation electrodes of a catheter and a reference electrode of a plurality of reference electrodes, and wherein the impedance measurements are obtained between each neuromodulation electrode of the plurality of neuromodulation electrodes of the catheter and at least two reference electrodes of the plurality of reference electrodes;
create an impedance map of an anatomical environment at or near a target site based on the impedance measurements, wherein the impedance map indicates effects of the anatomical environment on an electric field induced by the plurality of electrode groups; and
select, based on the impedance map, at least one electrode group for subsequent delivery of neuromodulation energy to the target site by at least one of:
comparing each impedance measurement of the impedance measurements to at least one reference impedance value and selecting the at least one electrode group for which the impedance measurement exceeds the at least one reference impedance value, or
comparing each impedance measurement of the impedance measurements to at least one other impedance measurement of the impedance measurements and selecting the at least one electrode group for which the impedance measurement exceeds the at least one other impedance measurement.

### Claim 2 (depends on 1)

The system of claim 1, further comprising the catheter, wherein the catheter includes an elongate shaft including a distal portion configured to be positioned in a blood vessel of a patient proximate the target site, wherein:
the plurality of neuromodulation electrodes is on the distal portion of the shaft, and
the plurality of reference electrodes is separate from the catheter.

### Claim 3 (depends on 2)

The system of claim 2, wherein the distal portion of the shaft is configured to be positioned in at least one of a renal artery main vessel, a main bifurcation of the renal artery, or one or more renal branches distal of the main bifurcation of the renal artery.

### Claim 4 (depends on 2)

The system of claim 2, wherein the distal portion of the shaft is configured to transform into a helical or a spiral shape to position at least one neuromodulation electrode of the plurality of neuromodulation electrodes in contact with a wall of the blood vessel.

### Claim 5 (depends on 1)

The system of claim 1,
wherein the controller is configured to select the at least one electrode group by at least:
selecting, based on the impedance map, a first electrode group including a first neuromodulation electrode of the plurality of neuromodulation electrodes and a first reference electrode of the plurality of reference electrodes, and
selecting, based on the impedance map, a second electrode group including a second neuromodulation electrode of the plurality of neuromodulation electrodes and a second reference electrode of the plurality of reference electrodes,
wherein the controller is configured to select, based on the impedance map, the first electrode group and the second electrode group to achieve at least one of a desired direction or a desired three-dimensional shape of an electric field during the subsequent delivery of neuromodulation energy to the target site.

### Claim 6 (depends on 1)

The system of claim 1, wherein the controller is configured to select, based on the impedance map, the at least one electrode group by at least comparing each impedance measurement of the impedance measurements to at least one reference impedance value.

### Claim 7 (depends on 1)

The system of claim 1, wherein the controller is configured to select, based on the impedance map, the at least one electrode group by at least comparing each impedance measurement of the impedance measurements to at least one other impedance measurement of the impedance measurements.

### Claim 8 (depends on 1)

The system of claim 1,
wherein prior to selecting the at least one electrode group for the subsequent delivery of neuromodulation energy to the target site, the controller is configured to control a medical device to deliver neuromodulation energy to the target site via at least one neuromodulation electrode of the plurality of neuromodulation electrodes and a particular reference electrode of the plurality of reference electrodes, and
wherein the controller is configured to select, based on the impedance map, the at least one electrode group for the subsequent delivery of neuromodulation energy to the target site by at least maintaining a grouping of the at least one neuromodulation electrode with the particular reference electrode for the subsequent delivery of neuromodulation energy.

### Claim 9 (depends on 1)

The system of claim 1,
wherein prior to selecting the at least one electrode group for the subsequent delivery of neuromodulation energy to the target site, the controller is configured to control a medical device to deliver neuromodulation energy to the target site via at least one neuromodulation electrode of the plurality of neuromodulation electrodes and a particular reference electrode of the plurality of reference electrodes, and
wherein the controller is configured to select, based on the impedance map, the at least one electrode group for the subsequent delivery of neuromodulation energy to the target site by at least selecting a different neuromodulation electrode to group with the at least one reference electrode for the subsequent delivery of neuromodulation energy to the target site.

### Claim 10 (depends on 1)

The system of claim 1, further comprising a medical device configured to generate neuromodulation energy, wherein the controller is configured to control the medical device to deliver the neuromodulation energy using the selected at least one electrode group.

### Claim 11 (depends on 1)

The system of claim 1, further comprising a display, wherein the controller is configured to present at least one of the selected at least one electrode group or the impedance map via the display.

### Claim 12 (depends on 1)

The system of claim 1, further comprising the plurality of reference electrodes, wherein the plurality of reference electrodes is configured to be positioned on skin of a patient.

### Claim 13 (depends on 1)

The system of claim 1, wherein a number of reference electrodes is greater than of a number of neuromodulation electrodes.

### Claim 14

A system comprising:
a controller configured to:
obtain impedance measurements for a plurality of electrode groups, wherein each electrode group of the plurality of electrode groups includes a neuromodulation electrode of a plurality of neuromodulation electrodes of a catheter and a reference electrode of a plurality of reference electrodes, and wherein the impedance measurements are obtained between each reference electrode of the plurality of reference electrodes and at least two neuromodulation electrodes of the plurality of neuromodulation electrodes of the catheter;
create an impedance map of an anatomical environment at or near a target site based on the impedance measurements, wherein the impedance map indicates effects of the anatomical environment on an electric field induced by the plurality of electrode groups; and
select, based on the impedance map, at least one electrode group for subsequent delivery of neuromodulation energy to the target site by at least one of:
comparing each impedance measurement of the impedance measurements to at least one reference impedance value and selecting the at least one electrode group for which the impedance measurement exceeds the at least one reference impedance value, or
comparing each impedance measurement of the impedance measurements to at least one other impedance measurement of the impedance measurements and selecting the at least one electrode group for which the impedance measurement exceeds the at least one other impedance measurement.

### Claim 15 (depends on 14)

The system of claim 14, further comprising the catheter, wherein the catheter includes an elongate shaft including a distal portion configured to be positioned in a blood vessel of a patient proximate the target site, wherein:
the plurality of neuromodulation electrodes is on the distal portion of the shaft, and
the plurality of reference electrodes is separate from the catheter and is configured to be positioned on skin of the patient.

### Claim 16 (depends on 14)

The system of claim 14,
wherein prior to selecting the at least one electrode group for the subsequent delivery of neuromodulation energy to the target site, the controller is configured to control a medical device to deliver neuromodulation energy to the target site via at least one neuromodulation electrode of the plurality of neuromodulation electrodes and a particular reference electrode of the plurality of reference electrodes, and
wherein the controller is configured to select, based on the impedance map, the at least one electrode group for the subsequent delivery of neuromodulation energy to the target site by at least maintaining a grouping of the at least one neuromodulation electrode with the particular reference electrode for the subsequent delivery of neuromodulation energy.

### Claim 17 (depends on 14)

The system of claim 14, wherein the controller is configured to select the at least one electrode group by at least comparing each impedance measurement of the impedance measurements to at least one reference impedance value.

### Claim 18 (depends on 14)

The system of claim 14, wherein the controller is configured to select the at least one electrode group by at least comparing each impedance measurement of the impedance measurements to at least one other impedance measurement of the impedance measurements.

### Claim 19 (depends on 14)

The system of claim 14,
wherein prior to selecting the at least one electrode group for the subsequent delivery of neuromodulation energy to the target site, the controller is configured to control a medical device to deliver neuromodulation energy to the target site via at least one neuromodulation electrode of the plurality of neuromodulation electrodes and a particular reference electrode of the plurality of reference electrodes, and
wherein the controller is configured to select, based on the impedance map, the at least one electrode group for the subsequent delivery of neuromodulation energy to the target site by at least selecting a different reference electrode to group with the at least one neuromodulation electrode for the subsequent delivery of neuromodulation energy to the target site.

### Claim 20 (depends on 14)

The system of claim 14, further comprising a medical device configured to generate neuromodulation energy, wherein the controller is configured to control the medical device to deliver the neuromodulation energy using the selected at least one electrode group.

### Claim 21 (depends on 14)

The system of claim 14, further comprising a display, wherein the controller is configured to present at least one of:
the impedance map via the display, or
the selected at least one electrode group via the display.

### Claim 22

A method comprising:
obtaining, by a controller, impedance measurements for a plurality of electrode groups, wherein each electrode group of the plurality of electrode groups includes a neuromodulation electrode of a plurality of neuromodulation electrodes of a catheter and a reference electrode of a plurality of reference electrodes, and wherein the impedance measurements are obtained between:
each neuromodulation electrode of the plurality of neuromodulation electrodes of the catheter and at least two reference electrodes of the plurality of reference electrodes; or
each reference electrode of the plurality of reference electrodes and at least two neuromodulation electrodes of the plurality of neuromodulation electrodes;
creating, by the controller, an impedance map of an anatomical environment near a target site based on the impedance measurements, wherein the impedance map indicates effects of the anatomical environment on an electric field induced by the plurality of electrode groups; and
selecting, by the controller and based on the impedance map, at least one electrode group for subsequent delivery of neuromodulation energy to the target site by at least one of:
comparing each impedance measurement of the impedance measurements to at least one reference impedance value and selecting the at least one electrode group for which the impedance measurement exceeds the at least one reference impedance value, or
comparing each impedance measurement of the impedance measurements to at least one other impedance measurement of the impedance measurements and selecting the at least one electrode group for which the impedance measurement exceeds the at least one other impedance measurement.

### Claim 23 (depends on 22)

The method of claim 22, wherein selecting, based on the impedance map, the at least one electrode group comprises comparing each impedance measurement of the impedance measurements to at least one reference impedance value.

### Claim 24 (depends on 1)

The system of claim 1, wherein to select, based on the impedance map, the at least one electrode group, the controller is configured to compare each impedance measurement of the impedance measurements to at least one other impedance measurement of the impedance measurements.

### Claim 25 (depends on 1)

The system of claim 1, wherein the controller is configured to control, after selecting the at least one electrode group, a medical device to deliver neuromodulation energy using the selected at least one electrode group.
